Colombo, Marco
,
McGurnaghan, Stuart J.
Bell, Samira
MacKenzie, Finlay
Patrick, Alan W.
Petrie, John R.
McKnight, John A.
MacRury, Sandra
Traynor, Jamie
Metcalfe, Wendy
McKeigue, Paul M.
Colhoun, Helen M. http://orcid.org/0000-0002-8345-3288
Funding for this research was provided by:
Diabetes UK (10/0004010)
Juvenile Diabetes Research Foundation (1-SRA-2016-334-Q-R)
Chief Scientist Office (Ref. ETM/47)
Article History
Received: 22 July 2019
Accepted: 18 October 2019
First Online: 5 December 2019
Duality of interest
: HMC has received grants, personal fees and non-financial support from Eli Lilly & Company, grants from Pfizer Inc., grants from Boehringer Ingelheim, grants from AstraZeneca LP, grants, personal fees and non-financial support from Sanofi, non-financial support from Novartis Pharmaceuticals, personal fees and non-financial support from Regeneron, has received grants and holds shares at Roche Pharmaceuticals, is a shareholder in Bayer, has received non-financial support from Sanofi Aventis, outside the submitted work. All other authors declare that there is no duality of interest associated with their contribution to this manuscript. The study sponsors had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.